Ligand engagement by the receptor Fas leads to apoptosis. A clue to how this happens comes from the discovery that ligand binding leads to recruitment to Fas of a protease, homologous to interleukin-1␤ converting enzyme, likely to initiate a proteolytic cascade that drives apoptosis.
Like Fas, the TNF type I receptor (TNF-RI) also transduces an apoptotic signal. Fas and TNF-RI have a homologous region of about 80 amino acids in their cytoplasmic domains, which is essential for transduction of the death signal and hence known as a death domain [3, 4] . This death domain provides the link between cell-surface receptors such as TNF-RI and Fas and the intracellular apoptosis machinery. Recent results are beginning to unravel the chain of events that follows engagement of the Fas receptor and tells a cell that its time is up.
Unlike classical apoptosis, which is defined as a type of cell death that requires gene expression [1] , apoptosis induced by Fas or TNF-RI stimulation occurs in the presence of inhibitors of RNA or protein synthesis. Even enucleated cells undergo apoptosis upon Fas activation, suggesting that all the components necessary for the apoptotic signal transduction are present in the growing cells, and that Fas activation just triggers this machinery. To dissect the signal transducing machinery proximal to the Fas receptor, two approaches have been taken. Several groups used the yeast two-hybrid system to clone directly molecules that can bind to the Fas cytoplasmic region, while one group used more biochemical techniques to identify such molecules. Use of the yeast two-hybrid system quickly identified several molecules that can bind to Fas [5, 6] . One of these is a molecule known as the FADD (Fas-associating protein with a death domain) or MORT1, a 208-residue protein with a death domain at its carboxyl terminus. FADD/MORT1 binds to Fas via interactions between the death domains, while its amino-terminal region -the DED (death-effector domain) or MORT1 domain -is responsible for the downstream signal transduction. Subsequently, FADD/MORT1 was shown to be recruited to Fas when the latter is activated by ligand binding [7] .
Meanwhile, several groups have shown an involvement of interleukin-1␤ (IL-1␤) converting enzyme (ICE), or an ICE-like protease, in Fas-mediated apoptosis [8] . This strand of the story has its origins in genetic studies with the nematode Caenorhabditis elegans, which identified a number of genes that regulate apoptosis [9] . Among these genes, CED-3 was shown to be essential for the cell deaths that are a normal part of Caenorhabditis elegans development, and cloning of CED-3 showed that its product is a homologue of mammalian ICE [10] . ICE was originally identified as the enzyme that converts the IL-1␤ precursor to the mature form, an inflammatory cytokine. ICE is a cysteine protease consisting of two large (p17) and two small (p10) subunits, which are generated by proteolytic cleavage of its precursor.
ICE has turned out to be the prototype of a protease family that so far is known to have seven members, identified either by cross-hybridization with ICE cDNA or by searching the human genome database for ICE homologues; the family has been divided into three subgroups based on sequence relationships [11] . All of these seem to be cysteine proteases, having the characteristic conserved sequences for substrate binding and catalysis. Although in most cases the substrate specificities of the ICE homologs are not known, some clearly recognize a specific peptide sequence. Thus, ICE recognizes the sequence YVAD, cleaving after the aspartate (D), whereas CPP32 recognizes DEVD and cleaves poly(ADP-ribose) polymerase, and Mch2 recognizes VEVD and cleaves lamin [12] [13] [14] . Despite this apparent specialization, ICE mutant mice lack an obvious phenotype, which suggests that there is at least an element of functional redundancy among members of the ICE family [15] .
A good way of investigating the function of an enzyme is to use specific inhibitors, and there are several ways of inhibiting ICE family proteases. Knowledge of the specific sequences that they recognize has been used to design specific competitive inhibitors of ICE itself and CPP32. Thus, Ac-YVAD-aldehyde (cho) specifically inhibits ICE, whereas Ac-DEVD-cho inhibits CPP32. In addition, several virus proteins are known to inhibit ICE: these are the cowpox virus protein crmA, a 'cytokine response modifier', and the baculovirus protein p35. Using these inhibitors, it was shown that both ICE and CPP32 proteases are involved in Fas-mediated apoptosis [8, 16] .
By monitoring the protease activity of ICE and CPP32 using specific fluorescent substrates, it was demonstrated that ICE is transiently activated, and CPP32 more gradually activated, during Fas-induced apoptosis [16] . The activation of CPP32 is dependent on ICE activation, indicating that ICE and CPP32 are sequentially activated; this sequential protease activation has also been demonstrated in a cell-free system. Lysates from the Fas-activated, but not from non-activated cells, induce apoptotic morphological changes in intact nuclei [17] . When the lysates from the growing, non-apoptotic cells were supplemented with recombinant ICE or CPP32, they gained the ability to induce apoptosis. This ICE-induced apoptosis could be inhibited not only by an ICE inhibitor, but also by the CPP32 inhibitor [16] , confirming that their sequential activation really does reflect a pathway leading to apoptosis.
Ligand binding to Fas thus induces a protease cascade inside the Fas-expressing cell. But how does the intracellular domain of Fas, once activated, trigger this cascade? In an attempt to find the signaling molecule immediately downstream of FADD/MORT1, Wallach and colleagues [18] again used the yeast two-hybrid system, this time with the amino-terminal region of FADD/MORT1 as a bait. At the same time, a collaborative group led by Dixit and Peter [19] continued their biochemical characterization of the molecules that are recruited to oligomerized Fas. In these different ways, both groups have now identified the same molecule, which is called FLICE (FADD-like ICE) or MACH (MORT1-associated CED-3 homologue).
FLICE/MACH is a 55 kDa protein, with two DED/ MORT1 domains in the amino-terminal region required for binding to FADD/MORT1. A truncated form of the FLICE/MACH protein, containing only its amino-terminal DED domain, is also found associated with FADD/ MORT1 [19] . This fragment may be generated by proteolytic processing of FLICE/MACH: activation of FLICE/ MACH may release the carboxy-terminal, ICE-like domain, leaving the amino-terminal part attached to FADD/MORT1. The other possibility is the fragment is a product of alternative RNA splicing. Several mRNA species that code for just the amino-terminal part of FLICE/ MACH have been identified [18] . Overexpression of this amino-terminal fragment blocks Fas-induced apoptosis, suggesting that the sensitivity of the cells to the Fas-induced apoptosis is determined at least in part by alternative splicing of FLICE/MACH mRNA.
The carboxy-terminal region of FLICE/MACH is related to the ICE family members, more specifically to the members of the CPP32 subfamily, and recombinant MACH preferentially cleaves CPP32 substrates over the ICE substrates [18] . The following two models seem plausible ways of integrating these results into the sequential activation model of ICE proteases. In the first model, the oligomerization of FLICE/MACH through interaction with FADD/MORT1 leads to the autocatalytic activation of FLICE/MACH, which then triggers the protease cascade by cleavage of the ICE precursor (Fig. 1) . In the [20] . No mammalian homologue of CED-4 has been identified yet. As shown in Figure 2 , however, the DED/MORT domains of FLICE/MACH and FADD show significant homology to the carboxy-terminal region of CED-4. This suggests either that a putative mammalian CED-4 homologue is also recruited to the Fas receptor through FADD/MORT1, or that FLICE/MACH binds to the putative CED-4 homologue through its DED/MORT1 domain. The CED-4 product is necessary for CED-9 to block apoptosis [21] . Bcl-2, a mammalian homolog of CED-9, inhibits the Fasinduced apoptosis in vitro as well as in vivo [22, 23] . These observations may facilitate the analysis of Bcl-2 and CED-4, the functions of which are currently unknown.
In conclusion, the signal transduction mechanism leading to apoptosis was until recently obscure. The identification of a death-inducing ligand and receptor, and of intracellular signaling molecules downstream of the receptor, has shown that the decision to undergo apoptosis is an irreversible step involving a cascade of proteases. This apoptotic pathway seems to be much simpler than those involved in growth or differentiation, and could be a model for mechanisms by which other agents, such as anti-cancer drugs, oncogenes and irradiation, induce apoptosis. Various important human diseases, such as cancer and some autoimmune diseases, are often caused by inappropriately regulated apoptosis; the identification of the apoptotic signaling molecules and their modulators should certainly help further our understanding of such diseases.
Dispatch 1243

Figure 2
Presence of DED domain in the C. elegans CED-4 protein. The amino-acid sequences from FLICE/MACH, FADD/MORT1 and C. elegans CED4 are aligned to maximize their similarity. Amino acids that are identical or chemically similar among all three sequences are indicated by red letters, with and without yellow highlighting, respectively.
FLICE(3-57) FSRNLYDI GEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQ--EKRMLEES FADD(4-61)
FLVLLHSV SSSLSSSELTELKFLCLGRVGKRKLERVQSGLDLFSML--LEQNDLEPG CED4(422-480) DRLKRLSK GALLSGKRMPVLTF-KIDHIIHMFLKHVVDAQTIANGISILEQRLLEIG
